Accelerate Diagnostics Inc share price logo

Accelerate Diagnostics Inc Share Price

NASDAQ: AXDX

$0.04

-0.05

(-60.00%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 13 May 2025

Accelerate Diagnostics Inc Stock Performance

as on May 15, 2025 at 1:28 am IST

  • $0.04
    $0.04
  • 52 Week's Low

    52 Week's High

    $0.07
    $2.04
    downward going graph

    -82.00%

    Downside

    5000.00%

    Upside

    downward going graph

Accelerate Diagnostics Inc share price movements today

Previous Close
$0.09
Open
$0.04
Volume
17.6K
Day's Low - High
$0.04 - $0.04
52 Week Low - High
$0.07 - $2.04

Accelerate Diagnostics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Accelerate Diagnostics Inc Stock Fundamentals & Key Indicators

Check Accelerate Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

0.00%

Accelerate Diagnostics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Accelerate Diagnostics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%

Analyst Recommendation on Accelerate Diagnostics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Accelerate Diagnostics Inc. Average target price of $1.5

Accelerate Diagnostics Inc Share Price Target

Get share price movements and forecasts by analysts on Accelerate Diagnostics Inc.

What analysts predicted

97.33%UPSIDE

Target Price

$1.5

Current Price

$0.04

Analyzed by

7 Analysts

Target

$1.50

Accelerate Diagnostics Inc target price $1.5, a slight upside of 97.33% compared to current price of $0.04. According to 7 analysts rating.

Accelerate Diagnostics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
2
2
2
3
3
2
2
2
2
2
Gross Profit
0
1
0
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-17
-25
0
-13
-14
-11
-14
-9
-9
Net Profit Margin
-497.98%
-638.19%
-889.42%
27.58%
-433.33%
-487.16%
-388.08%
-492.07%
-340.52%
-340.52%

Accelerate Diagnostics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
4
5
9
11
11
12
12
11
Gross Profit
0
0
3
2
4
4
0
3
2
2
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-45
-66
-62
-88
-84
-78
-77
-62
-61
-50
Net Profit Margin
-30951.02%
-26981.30%
-1505.43%
-1557.78%
-906.80%
-700.47%
-659.50%
-490.06%
-510.97%
-427.81%

Global Institutional Holdings in Accelerate Diagnostics Inc

Funds
Holdings
Armistice Capital, LLC
8.24%
Hovey Youngman Associates Inc
3.38%
Vanguard Group Inc
1.9%
Geode Capital Management, LLC
0.54%
Spears Abacus Advisors LLC
0.45%

About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc. is in vitro diagnostics company engaged in providing solutions for the global challenges of antibiotic resistance and sepsis. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
OrganisationAccelerate Diagnostics Inc
E-voting on sharesClick here to vote

FAQs

What is Accelerate Diagnostics Inc share price today?

Accelerate Diagnostics Inc share price today is $0.04 as on at the close of the market. Accelerate Diagnostics Inc share today touched a day high of $0.04 and a low of $0.04.

What is the 52 week high and 52 week low for Accelerate Diagnostics Inc share?

Accelerate Diagnostics Inc share touched a 52 week high of $2.04 on and a 52 week low of $0.07 on . Accelerate Diagnostics Inc stock price today i.e. is closed at $0.04,which is 98.04% down from its 52 week high and -45.05% up from its 52 week low.

How to invest in Accelerate Diagnostics Inc Stock (AXDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Accelerate Diagnostics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accelerate Diagnostics Inc Shares that will get you 37.5000 shares as per Accelerate Diagnostics Inc share price of $0.04 per share as on May 15, 2025 at 1:28 am IST.

What is the minimum amount required to buy Accelerate Diagnostics Inc Stock (AXDX) from India?

Indian investors can start investing in Accelerate Diagnostics Inc (AXDX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Accelerate Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Accelerate Diagnostics Inc share’s latest price of $0.04 as on May 15, 2025 at 1:28 am IST, you will get 250.0000 shares of Accelerate Diagnostics Inc. Learn more about fractional shares .